Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Infographic – Q3 Health Care A.I. Funding Soars

Health care AI investments

In the third quarter of 2020, worldwide investments in artificial intelligence applications in health care rose to a new high, $2.1 billion. . . . → Read More: Infographic – Q3 Health Care A.I. Funding Soars

Keeping Your Business Out of Deep Debt

It is possible to avoid getting into deep debt, by which we mean the situation where you are genuinely struggling. . . . → Read More: Keeping Your Business Out of Deep Debt

Covid-19 Drug Biotech Raises $300M in IPO

Wall Street sign

A company developing a treatment for Covid-19 infections taken as a tablet instead of infusion issued its initial public offering, or IPO, for common stock. . . . → Read More: Covid-19 Drug Biotech Raises $300M in IPO

Will an R&D Department Help Your Small Business?

Any business can run a research and development team and it will help to push your company forward in a lot of different ways. . . . → Read More: Will an R&D Department Help Your Small Business?

FDA to Use Lung Chip Model for Covid-19 Testing

Emulate lung chip

The Food and Drug Administration plans to use organ-on-chip models to test mechanisms for preventing Covid-19 infections, and other processes. . . . → Read More: FDA to Use Lung Chip Model for Covid-19 Testing

Are These Science Fiction Concepts In Our Future?

Let’s explore some of these possibilities in turn to answer this question. . . . → Read More: Are These Science Fiction Concepts In Our Future?

Covid-19 Antibodies Cut Viral Load, Medical Visits

SARS-Cov-2 virus

Interim results from a clinical trial show a synthetic antibody drug reduces viral burden and medical visits among non-hospitalized Covid-19 patients. . . . → Read More: Covid-19 Antibodies Cut Viral Load, Medical Visits

200M Covid-19 Vaccine Doses Donated to Int’l Effort

Vaccine vials

Sanofi and GlaxoSmithKline are offering 200 million doses of their Covid-19 vaccine for a project devoted to making vaccines equitably available worldwide. . . . → Read More: 200M Covid-19 Vaccine Doses Donated to Int’l Effort

Helping an Employee Back Into the Office

What does it take to get an employee back to work in difficult times but also after an employee’s individual difficult time? . . . → Read More: Helping an Employee Back Into the Office

Novartis Gains Synthetic Protein Therapies for Covid-19

SARS-CoV-2 and cell

Global drug maker Novartis is gaining access to two Covid-19 therapy candidates made from a library of synthetic protein components. . . . → Read More: Novartis Gains Synthetic Protein Therapies for Covid-19